PROVENTIL-HFA (albuterol sulfate) by Teva is clinical pharmacology the prime action of beta-adrenergic drugs is to stimulate adenyl cyclase, the enzyme which catalyzes the formation of cyclic-3',5'-adenosine monophosphate (cyclic amp) from adenosine triphosphate (atp). First approved in 1996.
Drug data last refreshed 18h ago · AI intelligence enriched 1w ago
PROVENTIL-HFA is a metered-dose inhaler containing albuterol sulfate, a selective beta-2 adrenergic agonist that relaxes bronchial smooth muscle. It is used for the treatment and prevention of bronchospasm in patients with asthma and other obstructive airway diseases. The drug works by stimulating adenyl cyclase to increase cyclic AMP, producing rapid bronchodilation with onset of action within 5 minutes and peak effect at approximately 1 hour.
As an approaching LOE product with moderate competitive pressure (30/100), the brand team is likely consolidating resources and transitioning to lifecycle management strategies rather than growth expansion.
CLINICAL PHARMACOLOGY The prime action of beta-adrenergic drugs is to stimulate adenyl cyclase, the enzyme which catalyzes the formation of cyclic-3',5'-adenosine monophosphate (cyclic AMP) from adenosine triphosphate (ATP). The cyclic AMP thus formed mediates the cellular responses. In vitro…
Worked on PROVENTIL-HFA at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old
A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma
BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on PROVENTIL-HFA in an LOE-approaching environment offers career value primarily in defensive commercial strategy, managed care negotiations, and cost-containment initiatives rather than growth-oriented roles. This position is best suited for professionals seeking experience in lifecycle management, generic competition navigation, and portfolio transition strategies.